A Pilot Study On Using PEMF Therapy To Improve Mitochondrial Health In Older Adults

Overview

About this study

The purpose of this study is to quantify the acute/chronic effects of bioboosti PEMF therapy on mitochondrial health in older adults.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Between the ages of 58 and 78 years
Able to give informed consent

Exclusion Criteria:

Under age 58

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/04/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Bruce Johnson, Ph.D.	Contact us for the latest status

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Bruce Johnson, Ph.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Clinical Trials